Oramed Pharmaceuticals Inc. Chosen to Present at the XVI International Symposium on Atherosclerosis (ISA2012), (March 25-29, 2012; Sydney, Australia)
JERUSALEM--(BUSINESS WIRE)--Oramed Pharmaceuticals Inc. (OTCBB: ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today that its work entitled "Decreased CRP levels in response to a six-week, once-daily oral insulin regimen" will be presented at the XVI International Symposium on Atherosclerosis (ISA2012) on March 25-29, 2012, to be held in Sydney, Australia.